Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 15 Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Glioblastoma 7 Esophageal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 7 Uterine Cervical Neoplasms 6 Rhabdomyosarcoma 6 Esophageal Squamous Cell Carcinoma 5 Squamous Cell Carcinoma of Head and Neck 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Rhabdomyosarcoma, Embryonal 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Medulloblastoma 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Hodgkin Disease 3 Head and Neck Neoplasms 3 Gliosarcoma 3 Brain Neoplasms 3 Adenocarcinoma of Lung 3 Vaginal Neoplasms 2 Rhabdomyosarcoma, Alveolar 2 Prostate Adenocarcinoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroblastoma 2

Interventions

Radiation 1 Oxaliplatin 1 Irinotecan 1 Folfox protocol 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Locally Advanced Rectal Cancer × Radiation × Clear all

NCT02605265 2025-08-28

CinClare

Fudan University

Phase 3 Completed

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡